INTRODUCTION FROM CAROLIN SCHUMACHER, CEO
Welcome to GALVmed and thank you for your interest in this position!
We are a highly specialised organisation with an inspiring mission. Our mandate is to develop essential new livestock vaccines, pharmaceuticals and diagnostics and make these widely available to the hundreds of millions of small-scale farmers in the developing world who depend on livestock for their livelihoods. The way by which we do this is unique and the potential for improving livelihoods and rural economies is significant.
We are fortunate in receiving substantial funding from our long-term primary donors, the Bill and Melinda Gates Foundation and the UK Foreign and Commonwealth Office. With their support we are able to make progress as we work towards our vision. However, the challenges to secure financial support for our activity remain considerable and the need for exceptional talent and expertise in proposal development and fundraising is ever present.
In this role you will be working across all areas of GALVmed which encompasses:
• Research and Development: developing new and better vaccines, therapeutics and diagnostics with which small-scale farmers can better protect their livestock against major diseases in Africa and Asia.
• Market development: developing new and sustainable market supply mechanisms by which the vaccines and other products can become widely and sustainably available to millions of small-scale farmers.
• Enabling Environment: developing the necessary regulatory frameworks and alliances that will encourage private sector animal health investment in Africa and Asia.
• Monitoring and evaluation: assessing the impact of GALVmed’s work and promoting an organisational culture of learning.
Few positions span such a breadth of technical areas and the result is a truly fascinating and rewarding work environment. It will require both a strong motivation to learn and the ability to work closely with subject matter experts and build an extensive pipeline of new work projects and initiatives. The key value of the role is to secure the necessary funding, both through our existing and new donors, and thus contribute to GALVmed’s future sustainability.
Dr. Carolin L. Schumacher
CEO of GALVmed